Rex Healthcare’s venture capital unit will exit the cancer diagnostics system developer, which has agreed to an acquisition by Olympus.
Camera and optics technology manufacturer Olympus has agreed a $340m deal to buy Veran Medical Technologies, a US-based provider of cancer diagnostics systems, enabling hospital operator Rex Healthcare to exit.
Veran develops medical devices used for the diagnosis and treatment of various cancers. Its electromagnetic thoracic navigation system is capable of providing thoracic guidance for lung cancer treatments.
Olympus will acquire Veran through its Olympus Corporation of the Americas subsidiary, and the deal will allow it to combine its endoscope…
